Spice Bio is Developing a New Generation of Immune Checkpoint Inhibitors – PSCC

Spice Bio is Developing a New Generation of Immune Checkpoint Inhibitors – PSCC

Paris Saclay Cancer Cluster (PSCC) shared on LinkedIn:

PSCC BOOST Grant | Meet the Winners․ ՛Extraordinary results can come from ordinary science.՛

Meet Spice Bio, one of the 10 winners of the PSCC BOOST Grant.
Spice Bio is developing a new generation of immune checkpoint inhibitors (ICIs) with the ambition of broadening the benefits of immunotherapy for more patients.

In this video, Alan Korman, one of the pioneers behind modern cancer immunotherapy, shares why his team believes there is still tremendous potential to unlock the next generation of immune checkpoint inhibitors.

He also explains how the PSCC BOOST Grant will help strengthen Spice Bio’s research, generate the additional data needed to advance its innovative approach, and support the company’s continued growth.

Congratulations to the entire Spice Bio team. We are proud to support their journey through the PSCC BOOST Grant and look forward to following the next milestones in their development.

Watch Alan Korman’s testimonial below.
Over the coming weeks, discover the 10 winners of the PSCC BOOST Grant and the breakthrough innovations they are developing to shape the future of oncology.”

Watch the video

Other articles about on OncoDaily.